tru Independence’s Precigen PGEN Stock Holding History

tru Independence’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-49,004	Closed	-$245K	–	699
2020 Q2	$245K	Sell	49,004 -19,600	-29%	-$66.7K	0.04%	229
2020 Q1	$233K	Hold	68,604	–	–	0.04%	191
2019 Q4	$233K	Buy	+68,604	New	+$386K	0.03%	232

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return

tru Independence's PGEN Position: Q3 2020 in Review

tru Independence sold out of Precigen (PGEN) in Q3 2020, closing a stake of 49,004 shares — an estimated $245K sold.

tru Independence first reported a position in PGEN in Q4 2019 and held it in 3 quarters. The position peaked at $245K in Q2 2020. 159 funds tracked by Wall St. Rank hold PGEN as of Q3 2020.

tru Independence reported no remaining Precigen position as of Q3 2020 after selling out during the quarter.
tru Independence sold 49,004 Precigen shares in Q3 2020, an estimated $245K.
tru Independence first reported a position in Precigen in Q4 2019 and held it in 3 quarters.
tru Independence's Precigen position peaked at $245K in Q2 2020.
159 funds tracked by Wall St. Rank held Precigen as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.